# Efficacy and Safety of Probiotics for Anxiety Depression

> **NCT07331987** · NA · NOT_YET_RECRUITING · sponsor: **Moon (Guangzhou) Biotechnology Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Anxiety Depression

## Interventions

- **DRUG:** Probiotic
- **DRUG:** Placebo
- **COMBINATION_PRODUCT:** Escitalopram

## Key facts

- **NCT ID:** NCT07331987
- **Lead sponsor:** Moon (Guangzhou) Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07331987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07331987, "Efficacy and Safety of Probiotics for Anxiety Depression". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07331987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*